Cancer epigenetics comes of age - PubMed (original) (raw)
Review
doi: 10.1038/5947.
Affiliations
- PMID: 9988266
- DOI: 10.1038/5947
Review
Cancer epigenetics comes of age
P A Jones et al. Nat Genet. 1999 Feb.
Abstract
The discovery of numerous hypermethylated promoters of tumour-suppressor genes, along with a better understanding of gene-silencing mechanisms, has moved DNA methylation from obscurity to recognition as an alternative mechanism of tumour-suppressor inactivation in cancer. Epigenetic events can also facilitate genetic damage, as illustrated by the increased mutagenicity of 5-methylcytosine and the silencing of the MLH1 mismatch repair gene by DNA methylation in colorectal tumours. We review here current mechanistic understanding of the role of DNA methylation in malignant transformation, and suggest Knudson's two-hit hypothesis should now be expanded to include epigenetic mechanisms of gene inactivation.
Similar articles
- Dormant hypermethylated tumour suppressor genes: questions and answers.
Esteller M. Esteller M. J Pathol. 2005 Jan;205(2):172-80. doi: 10.1002/path.1707. J Pathol. 2005. PMID: 15643671 Review. - DNA methylation, imprinting and cancer.
Plass C, Soloway PD. Plass C, et al. Eur J Hum Genet. 2002 Jan;10(1):6-16. doi: 10.1038/sj.ejhg.5200768. Eur J Hum Genet. 2002. PMID: 11896451 Review. - [The roles of DNA methylation in human neoplasms].
Yuan YF, Li JQ, Yang ZL, Wang JP. Yuan YF, et al. Ai Zheng. 2002 Nov;21(11):1267-77. Ai Zheng. 2002. PMID: 12526230 Review. Chinese. - CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M. Esteller M. Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review. - DNA hypermethylation: when tumour suppressor genes go silent.
Garinis GA, Patrinos GP, Spanakis NE, Menounos PG. Garinis GA, et al. Hum Genet. 2002 Aug;111(2):115-27. doi: 10.1007/s00439-002-0783-6. Epub 2002 Jul 16. Hum Genet. 2002. PMID: 12189484 Review.
Cited by
- Liquid biopsy for early detection of lung cancer.
Bibikova M, Fan J. Bibikova M, et al. Chin Med J Pulm Crit Care Med. 2023 Oct 20;1(4):200-206. doi: 10.1016/j.pccm.2023.08.005. eCollection 2023 Dec. Chin Med J Pulm Crit Care Med. 2023. PMID: 39171286 Free PMC article. Review. - Triggering Receptor Expression on Myeloid Cells-1 (TREM1) Promoter Hypomethylation and Its Overexpression Associated With Poor Survival of Cancer Patients: A Pan-Cancer Analysis.
Ruskin P, Pandi C, Kannan B, Pandi A, A S SG, Jayaseelan VP, Arumugam P. Ruskin P, et al. Cureus. 2024 Jul 16;16(7):e64640. doi: 10.7759/cureus.64640. eCollection 2024 Jul. Cureus. 2024. PMID: 39149674 Free PMC article. - Unveiling Bladder Cancer Prognostic Insights by Integrating Patient-Matched Sample and CpG Methylation Analysis.
Kim C, Oh S, Im H, Gim J. Kim C, et al. Medicina (Kaunas). 2024 Jul 19;60(7):1175. doi: 10.3390/medicina60071175. Medicina (Kaunas). 2024. PMID: 39064604 Free PMC article. - A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors.
Buckley DN, Tew BY, Gooden C, Salhia B. Buckley DN, et al. NPJ Precis Oncol. 2024 Jun 1;8(1):125. doi: 10.1038/s41698-024-00590-1. NPJ Precis Oncol. 2024. PMID: 38824198 Free PMC article. - Identification of Eleutherococcus senticosus NAC transcription factors and their mechanisms in mediating DNA methylation of EsFPS, EsSS, and EsSE promoters to regulate saponin synthesis.
Dong J, Zhao X, Song X, Wang S, Zhao X, Liang B, Long Y, Xing Z. Dong J, et al. BMC Genomics. 2024 May 31;25(1):536. doi: 10.1186/s12864-024-10442-8. BMC Genomics. 2024. PMID: 38816704 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources